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ABSTRACT
Background: Preliminary studies have shown the potential use of saliva in the diagnosis of
chronic kidney disease (CKD). For saliva to completely replace serum as a diagnostic and
monitoring tool for CKD, studies must be done to determine its effectiveness as a substitute
in diagnosing chronic kidney disease, at each stage of the disease.
Aim: The aim of the study was to evaluate the role of saliva as a safe and non-invasive
alternative to serum, for creatinine estimation, in all stages of chronic kidney disease.
Method: A cross sectional study was conducted at the Renal Unit of Tygerberg Hospital, on
230 patients at all stages of CKD. Informed consent was obtained; thereafter saliva and serum
samples were collected for creatinine analysis. Correlation between serum and salivary
creatinine was determined using Spearman’s correlation test. Receiver Operating
Characteristics (ROC) analysis was used to determine the diagnostic ability of salivary
creatinine and a cut-off value for sensitivity and specificity of salivary creatinine to diagnose
CKD with GFR < 60ml/min was obtained.
Results: Serum creatinine values ranged from 46µmol/L to 1581µmol/L with a median value
of 134µmol/L. Salivary creatinine values ranged from 3µmol/L to 400µmol/L with a median
of 11µmol/L. Spearman’s correlation analysis showed a strong positive correlation (r = 0.82)
between serum and salivary creatinine values for all CKD stages. Linear regression analysis
of serum and salivary creatinine for CKD patients was significant in all CKD stages, except
for stage 1. Area under the curve for salivary creatinine was 0.839. A cut-off value of
8.50µmol/L showed a sensitivity of 78.3% and specificity of 74.0% at eGFR < 60ml/min, for
classifying patients as having CKD.
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Conclusion: The results support the potential of salivary creatinine as a non-invasive
diagnostic tool for estimating serum creatinine in patients with chronic kidney disease.
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CHAPTER 1: INTRODUCTION
Chronic kidney disease (CKD) has been defined as abnormalities of kidney structure or
function, present for greater than 3 months, with implications for health (Levin et al., 2013).
CKD is an important chronic disease worldwide (Ruggenenti et al., 2001) and one major
reason for this, is the increase in new cases of diabetes mellitus (Wild et al. 2004) and
hypertension (Gupta, 2004). CKD has a big impact on the quality of life of people suffering
from the disease (Levey et al., 2003) and is a major risk factor for the development of heart
disease and stroke.
The number of new cases of chronic kidney disease per annum is about 337 per million
population (pmp) in United States of America and about 95 pmp in the United Kingdom
(Proctor et al., 2005).  The burden of CKD in sub-Saharan Africa countries is sparsely
documented, although their incidence rates are speculated to be 3-4 times higher than those
reported in developed countries (Naicker et al. 2009). Studies on the prevalence of CKD in
sub-Saharan Africa reported a CKD prevalence range of 2% to 30% (Stanifer et al., 2014;
Adeniyi et al., 2017). A prevalence of 17.3% was reported in a suburban South African
population of mixed ancestry (Matsha et al., 2013).
A diagnosis of CKD is usually established using serum creatinine levels to calculate the
glomerular filtration rate (GFR) and the urinary albumin/creatinine ratio or urinary
protein/creatinine ratio, to detect proteinuria. To assess the severity of CKD and ensure
appropriate patient management, the Kidney Disease Improving Global Outcomes (KDIGO)
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group recommended the classification system below (Andrassy, 2013). It is based on the
cause, GFR, albuminuria levels and links the disease severity to risks of adverse outcomes.
Table 1: Definition and classification of chronic kidney disease. Kidney Disease:
Improving Global Outcomes (KDIGO). Kidney Int 2012.
The procedure for collection of blood for serum analysis is invasive and needs a trained
professional. A simple accurate diagnostic test that provides a reliable evaluation of disease
status and stages would be beneficial to both patients and clinicians.
Saliva contains various analytes that can be used to detect systemic diseases or provide
evidence of exposure to harmful substances. Due to the application of new scientific
approaches such as bioinformatics, metabolomics, genomics and proteomics, the saliva
research field is growing fast (Ahmadi et al., 2010). The advantage of saliva is that sample
collection is non-invasive and can be performed by the patient, with little involvement from
http://etd.uwc.ac.za/
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the health care provider (Kaufman and Lamster 2002). It may be a cost-effective procedure
for the screening of a large number of people (Lee et al., 2009). Using saliva will be
particularly advantageous to patients suffering from clotting disorders and those with difficult
venous access (Bayraktar et al., 2009; Kaufman and Lamster, 2002).
The potential use of saliva to detect various local diseases including oral, head and neck
cancers (St John et al., 2004) as well as systemic diseases such as type 2 diabetes, lung,
pancreatic, breast and ovarian cancers, has been established (Rao et al, 2009; Gao et al, 2009;
Zhang et al., 2010; Lee et al., 2012). Further studies are needed to standardize the diagnostic
use of saliva (Pfaffe et al. 2011; Gr¨oschl, 2008).
Few studies have explored the potential of saliva to diagnose and monitor the progression of
CKD (Venkatapathy et al., 2014; Bader et al., 2015; Lasisi et al., 2016). The present study
investigated the diagnostic value of salivary creatinine as an alternative to serum creatinine.
http://etd.uwc.ac.za/
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CHAPTER 2: LITERATURE REVIEW
Chronic kidney disease is one of the major chronic diseases worldwide (Ruggenenti et al.,
2001) and one major reason is the daily global increase in new cases of diabetes-mellitus
(Wild et al., 2004) and hypertension (Gupta, 2004). Chronic kidney disease is a problem of
high public health concern because it affects quality of life (Levey et al., 2003). A recent
systematic review reported global prevalence values of CKD stages 1 to 5 as being 13.4%
and 10.6% in stages 3 to 5 (Hill et al., 2016). The burden of chronic kidney diseases in sub-
Saharan Africa is sparsely documented and Naicker (2009) suggested that the incidence rates
in sub-Saharan Africa may triple the number reported in developed countries. Prevalence
values ranging from 6.1% to 17.3% have been reported in a mixed ancestry cohort in
suburban Western Cape, South Africa (Adeniyi et al., 2017; Matsha et al., 2013).
Chronic kidney disease needs frequent serum analysis of venous blood for diagnosis,
monitoring drug outcomes during management and to determine patient prognosis. The
kidneys primarily excrete creatinine, a waste product of muscle metabolism. Its serum level is
used to estimate the glomerular filtration rate. The procedure for collecting blood for serum
analysis is an invasive one, causing both discomfort and anxiety to patients. Thus, a
diagnostic test that provides a reliable evaluation of disease status and stages, with less risk,
would be of value to both the patients and health care providers.
Saliva has numerous analytes to help detect various systemic diseases and determine disease
severity. Saliva has the advantage over serum because the procedure for salivary collection is
non-invasive, easy to do, economical and its collection requires little participation from the
health care provider (Kaufman and Lamster, 2002). When required, a repeat sample can be
easily accessed. Salivary samples can also be used for the screening large numbers of people
http://etd.uwc.ac.za/
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with less cost implications than haematological sampling (Lee et al., 2009). Saliva as a
diagnostic medium could be valuable to patients with clotting disorders and those with
compromised venous access (Bayraktar et al., 2009; Kaufman and Lamster, 2002).
Several studies have shown that saliva can be used to detect disease conditions such as
pancreatic, lung and breast cancer, renal disease and type II diabetes (Malamud, 2011).
However, for these findings to be generally accepted, further scientific studies for each
disease is needed, to standardize the diagnostic value of saliva with other body fluids (Pfaffe
et al., 2011; Gr¨oschl, 2008).
For saliva to replace blood as a diagnostic and monitoring tool for patients with CKD, studies
must be designed to determine the effectiveness of saliva as a substitute to blood in
diagnosing chronic kidney disease at the various stages. A few studies (Venkatapathy et al.,
2014; Lasisi et al., 2016; Bader et al., 2015) have explored the possibility but none have been
established its diagnostic role of saliva for all stages of CKD, nor its role in monitoring
disease progression from one stage to another.
Detection and Classification of CKD patients
The Kidney Disease Outcomes Quality Initiative (KDOQI) developed guidelines for the
detection and evaluation of chronic kidney disease (Levin, et al., 2013; Andrassy, 2013).
These guidelines (Levin et al. 2013) defined CKD and outlined treatment goals for each
stage.
KDOQI recommended that CKD classification should be based on cause, GFR estimation
(eGFR) and albuminuria categories.  This recommendation is important because including
http://etd.uwc.ac.za/
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cause and severity in the classification, links to risks of adverse outcomes such as mortality
and kidney status, which will guide management of CKD.
Causes of CKD
CKD occurs as a result of primary kidney disease or underlying systemic diseases
secondarily affecting the kidney (Table 3). The guidelines recommend that all patients be
assessed for risk factors associated with kidney disease, where after patients with identifiable
risk factors receive further screening. The high-risk conditions for CKD include diabetes,
hypertension, family history of CKD, recurrent urinary tract infections or systemic conditions
affecting the kidneys (Andrassy, 2013).
Estimated Glomerular Filtration Rate (eGFR)
Glomerular filtration, the first step in urine formation, is the passive ultrafiltration of plasma
across the glomerular capillaries into Bowman's space. Glomerular filtration rate (GFR) is an
indication of kidney function. GFR cannot be measured directly, but assessed from clearance
measurements or estimated from serum levels of endogenous filtration markers, such as
creatinine or cystatin C (Snyder and Pendergraph, 2005). Creatinine clearance rate is the
volume of blood plasma that is cleared of creatinine per unit time and is a useful measure for
approximating the GFR. However, creatinine clearance overestimate GFR due to active
secretion of creatinine in the proximal tubules of the kidneys. Glomerular filtration rate
estimated from endogenous makers is known as estimated GFR (eGFR) and is used in
clinical practice to diagnose and monitor CKD patients.
Current KDOQI guidelines (Levin, et al., 2013; Andrassy, 2013) for screening of CKD use
serum creatinine and albumin. The latter is obtained from random urine samples.
http://etd.uwc.ac.za/
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The serum creatinine level is used to calculate an estimated glomerular filtration rate (eGFR).
The two most commonly used equations used to calculate eGFR are Modification of Diet in
Renal Disease (MDRD) Study equation and Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) equation (Table 2). In general, eGFR estimating equations include
age, sex, race, and body size as surrogates for creatinine generation by muscle. The CKD-
EPI equation was developed in 2009 and uses the same four variables as the MDRD Study
equation (Levey et al. 2009). MDRD and CKD-EPI both use the same variables, but differ in
the values used in their calculation. The CKD-EPI equation is less biased than the MDRD
study equation, especially at GFR≥60 ml/min/1.73 m2, a small improvement in precision and
greater accuracy. (Gonwa et al., 2004). An ethnicity factor of 1.212, adopted for African
American for the four variable MDRD study equation was found to overestimate mGFR in
black South Africans (Hendrick et al., 2008). Hendrick et al. (2008) found that the four
variable MDRD equation without the use of the ethnicity factor minimally overestimated
mGFR and therefore suggested that the ethnicity factor of 1.212 should not be used MDRD
equation in black South African.
http://etd.uwc.ac.za/
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Table 2: Common equations used for the calculation of eGFR
MRDR equation CKD-EPI equation
Albuminuria
Albuminuria, which is the presence of protein albumin in urine, has also been used to classify
CKD. An albumin:creatinine ratio < 30mg/g is considered normal, while albumin:creatinine
ratios > 30mg/g in urine is considered diagnostic for CKD (Baumgarten and Gehr, 2011)
(Table 1).
http://etd.uwc.ac.za/
  
 
 
9
Table 3: Classification of CKD based on presence or absence of systemic disease and
location within kidney of pathologic-anatomic findings
Saliva as a diagnostic tool for CKD
The use of human saliva as a diagnostic and prognostic indicator of CKD, has only recently
received attention (Venkatapathy et al. 2014; Lasisi et al., 2016)
Studies (Venkatapathy et al. 2014; Lasisi et al., 2016; Bader et al., 2015; Xia et al., 2012)
showed conflicting evidence when comparing salivary and serum creatinine levels of CKD
patients and healthy people. Venkatapathy et al. (2014) only found a positive correlation
(r=0.731) between salivary and serum creatinine levels in patients with chronic kidney
disease and a negative correlation in healthy control (r = -0.326). However, Xia et al. (2012)
found a positive correlation in both their cases ( = 0.971) and healthy control ( =0.932).
The positive correlation found in CKD patients may be due to the concentration gradient
created by the increased serum creatinine levels in the CKD patients’ saliva (Nakahari et al.,
1996) and alteration in the permeability of the salivary gland cells, allowing creatinine to
diffuse easily through the tight intercellular junction of the salivary gland. Previous studies
reported a negative correlation in healthy controls (Venkatapathy et al., 2014; Lasisi et al.,
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2016; Bader et al., 2015). The high molecular weight and low lipid solubility of creatinine
make it difficult to cross the tight intercellular junction of the salivary gland in health (Lamb
et al., 2006). However, Xia et al. (2012) found a positive correlation between salivary and
serum creatinine levels in both their chronic kidney disease patients and healthy controls.
Seethalakshmi et al. (2014) reported a significant correlation between salivary and serum
creatinine levels in late stages of CKD. Bader et al (2015) found that the salivary creatinine
concentrations of patients in the middle  and  late stages  of chronic kidney disease were
higher  than  those  of  healthy  people  and  early-stage CKD  patients.
Though studies have been done to correlate the salivary and serum creatinine levels
(Venkatapathy et al., 2014; Lasisi et al., 2016; Bader et al., 2015), no known study has
evaluated its diagnostic use in all stages of chronic kidney disease.
Mechanism of expression of serum creatinine in saliva
Creatinine is a metabolic waste product, primarily excreted by the kidneys. Virtually all the
creatinine filtered by the glomerulus is excreted without reabsorption in the renal tubules and
its level in the blood is used as an index of renal function (Guyton and Hall, 2006).
However, as renal function decreases, GFR decreases leading to an increase tubular secretion
of creatinine. Increasing tubular creatinine secretion is usually considered to be due to greater
interstitial creatinine concentration to which tubular cells are exposed as CKD progresses
(Rose et al., 2001). Salivary glands are surrounded by many capillaries and are highly
permeable, facilitating the free exchange of blood-based molecules into the salivary gland
acini. The transport of molecules into salivary gland occurs via either transcellular (passive
and active transport) or paracellular (extra cellular ultrafiltration) diffusion mechanisms
http://etd.uwc.ac.za/
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(Yoshizawa et al., 2013). Diffusion of molecules is considered to be the common route for
movement of molecules from blood to saliva and the ability of molecules to diffuse depends
on the size and the electric charge of the molecules (Nagarathinam et al., 2017).
Salivary creatinine is about 10-15% of the serum levels (Nagarathinam et al., 2017). The
normal range of serum creatinine in females is 45‑84 µmol/L while the normal range in males
is 59‑104 µmol/L (Mazzachi et al., 2000)) and salivary creatinine is 4.42µmol/L -
17.68µmol/L (Venkatapathy et al., 2014). The expression of serum creatinine in saliva is due
to the ultrafiltration of creatinine into saliva. Ultra-filtration is an extra cellular mechanism
for transport of blood substances into saliva by filtration through the spaces between the
acinus and the ductal cells. Only very small sized molecules can be transported through ultra-
filtration and filtration may also occur through the gap junctions between cells of secretory
units.
When a molecule’s concentration increases in blood, a corresponding increase in diffusion of
these molecules occurs into the saliva, with an associated increased concentration of the
salivary markers (Yoshizawa et al., 2013). Similarly, when serum creatinine levels are
increased, so too is their concentration in saliva. The increase in salivary creatinine due to
concentration gradient diffusion makes saliva a potential tool for measuring renal function.
Gap in literature
Although the previous studies suggest that saliva may be useful as a substitute for serum
creatinine, most of these studies only focused on the level of salivary creatinine in the end
stages of chronic kidney disease (Venkatapathy et al. 2014). None of these studies assessed
the diagnostic value of salivary creatinine at each stage of chronic kidney disease in order to
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provide evidence for substituting saliva for serum to diagnose and monitor chronic kidney
disease. Venkatapathy et al. (2014) concluded that more scientific studies are needed to
investigate the diagnostic value of salivary creatinine at all stages of chronic kidney disease.
Methods of saliva collection
Sample collection can be performed by either unstimulated (spitting directly into a tube) or
stimulated methods. The former is preferred because most analytes (such as proteins) can be
quantified without any changes in their usual quantification (Hansen et al. 2003; Turpeinen et
al. 2009). However, the volume of saliva collected by this method is low (Burtis and Bruns
2014). Stimulated saliva is obtained by stimulating the salivary glands using substances such
as citric acid or by mastication (Kaufman and Lamster 2002). Saliva collection from
individual glands can be done by cannulation of the salivary gland duct or by connecting
specific collecting devices to the glandular duct openings into the mouth. These procedures
are slow, complex, uncomfortable, technique sensitive and not the preferred method of
collection (Chianeh and Prabhu 2014).
The spitting method was the preferred one in most studies (Venkatapathy et al. 2014; Bader
et al., 2015; Lasisi et al., 2016). Timing of the sample collection is also important and
influences the specific constituents available for analysis. Venkatapathy et al. (2014) in their
study, regarded 9am to 11am as optimum collection time. Smoking, food or liquid ingestion
(except water) should be avoided an hour before collection of unstimulated saliva because it
can affect its constituents. Rinsing of the mouth with water before collection is important, as
it helps to remove any residues that may interfere with the analyses (Nunes et al. 2011)
http://etd.uwc.ac.za/
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After sample collection, the saliva should be preserved at around 4 °C, if not processed
immediately and can be kept for a maximum of 6 hours. Sample storage at −20°C to −80 °C
is recommended if the sample needs to be preserved for a longer duration, to prevent further
protein degradation (de Jong et al., 2011).
Analysis of Saliva
The different components of saliva can be used to evaluate, diagnose and monitor most
common systemic conditions.
Jaffe’s reaction is the most widely used for creatinine measurement (Krishnegowda et al.
2013). However, this method is deficient in sensitivity, reproducibility, and precision in the
presence of interfering substances, which could be endogenous or exogenous (Weber and
Zanten, 1991). These include Bilirubin, creatine, dopamine, ascorbic acid and
cephalosporines. Jaffe’s method has since been modified to eliminate some of the drawbacks,
such as the specific adsorption of creatinine, removal of interfering compounds, dialysis,
varying the pH, and kinetic measurements. None of these modifications have successfully
removed the interferants present in biological samples.
Jaffe’s method has more recently been modified using some multi-enzyme systems to
improve its specificity for detecting creatinine in biological samples. The use of multi-
enzyme systems however, requires caution, as there is an increased risk of interference
between the enzymes (Krishnegowda et al. 2013).
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Table 4: Positive and negative interference of Jaffe’s reaction
Positive Interference Negative interference
Acetone Bilirubin
Cefazolin Lipids
Cefoxitin Acetoacetic acid
Glucose Phenacemide
Other methods available for creatinine analysis include the use of reagents such as 3,5-di-
nitrobenzoic acid, a mixture of dimethyl sulfoxide, methanol and tetramethyl ammonium
hydroxide, 3,5-dinitrobenzoyl chloride, 1,4-naphthoquinone-2-sulfonate, Sakaguchi’s color
reaction of creatinine with o-nitrobenzaldehyde  and mass fragmentography (Krishnegowda
et al. 2013; Peake and Whiting, 2006). Estimation of creatinine by direct spectrophotometric
procedure has recently been attempted (Krishnegowda et al. 2013).
The only alternative methods that have been widely adopted for routine clinical laboratory
use are enzymatic creatinine methods (Myers et al., 2006). This enzymatic method is based
on the conversion of creatinine with the aid of creatininase, creatinase, and sarcosine oxidase
to glycine, formaldehyde and hydrogen peroxide. Catalyzed by peroxidase the liberated
hydrogen peroxide reacts with 4‑aminophenazone and HTIB to form a quinone imine
chromogen.
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Creatinine measurement has recently be Standardized by NKDEP’s Laboratory Working
Group in conjunction with the International Federation of Clinical Chemistry and Laboratory
Medicine (IFCC) and the European Communities Confederation of Clinical Chemistry to
reduce inter-laboratory variation in calibration of creatinine assay (Piéroni et al., 2017). The
National Institute for Standards and Technology (NIST) has released a standard reference
material useful in establishing calibrations for routine creatinine measurement procedures,
with demonstrated commutability with native clinical specimens in routine methods. The
standard reference materials were value-assigned with the gas chromatography (GC) -isotope
dilution mass spectrometry (IDMS) and liquid chromatography (LC)-IDMS reference
measurement procedures (Dodder et al., 2007).
Since the standardization of creatinine, manufacturers have been asked to standardize their
creatinine assays to an IDMS reference measurement procedure. This has helped to ensure
that the same sample give the same result irrespective of the laboratory and the method used
(Jaffe or enzymatic) (Carobene et al., 1997).
http://etd.uwc.ac.za/
  
 
 
16
Clinical Benefit of this study
Saliva has the advantage over serum because its collection is non-invasive, economical and
can be done with minimal assistance from the health care provider (Kaufman and Lamster,
2002). When needed, a repeat salivary sample can be collected, with less patient discomfort.
Saliva as a diagnostic medium would be valuable to patients suffering from clotting disorders
and for those with compromised venous access (Bayraktar et al., 2009; Kaufman and Lamster
2002). Thus, a simple diagnostic test that provides a reliable evaluation of disease status at
various stages would benefit both patients and health care providers.
Conclusion
The incidence and prevalence of chronic kidney disease is increasing globally, thus the
development of a reliable, less invasive tool for early diagnosis and patient monitoring would
be beneficial. Saliva is a rich source of protein biomarkers and has potential as a point of care
method to diagnose and monitor chronic kidney disease.
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CHAPTER 3: RESEARCH METHODOLOGY
3.1     Introduction
This chapter discusses the aims and objectives of the study as well as its research design and
methodology. Tygerberg hospital is a tertiary referral facility. The clinical management of
patients with chronic kidney disease is based in the Renal Unit at Tygerberg Hospital, which
has a well-equipped ward for in-patient management and two weekly morning outpatient
clinics. Serum creatinine measurement is the internationally accepted method to diagnose and
monitor chronic kidney disease. The present study investigated the use of saliva as an
alternative for the diagnosis of chronic kidney disease.
Patients recruited for this study were classified according to the guidelines of KDOQI. The
CKD classification was based on GFR, which is calculated using CKD-EPI equations
estimated by serum creatinine level. Patients were grouped into five stages using the CKD-
EPI equations for estimating GFR. Variables included in the CKD-EPI equation for
estimating GFR are log serum creatinine, sex, race and age on the natural scale.
http://etd.uwc.ac.za/
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Table 5: The CKD-EPI equations for estimating GFR on the natural scale
3.2 Aims and Objectives
The aim of the study was to evaluate the role of saliva as a safe and non-invasive alternative
to serum, for creatinine estimation, in patients with chronic kidney disease.
The objectives of this study were:
 To determine the average diagnostic value of salivary creatinine at all stages
of chronic kidney disease.
 To correlate the levels of salivary creatinine with serum creatinine at each
stage of chronic kidney disease.
3.3 Research design
In this cross sectional study, data (saliva and serum samples) was collected from patients in
the various stages of chronic kidney disease at a single visit.
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3.4 Sampling criteria
A convenient sampling method was employed to choose participants who met the selection
criteria. Consecutive patients, who presented to the Renal Unit outpatient clinic on
Wednesday and Friday mornings, were recruited until the required sample size was obtained.
The CKD category into which patients’ were enrolled was based on their CKD stage as
determined by the previous laboratory measurements of serum creatinine not older than three
months.
3.4.1 Inclusion criteria
• Patients 18 years and above with a confirmed diagnosis of CKD.
• Patients who signed the consent form.
3.4.2 Exclusion criteria
Participants with any oral condition causing active bleeding into the oral cavity.
3.5 Sample size
The minimum sample size required was calculated using the estimated means of salivary
creatinine in a known test and control (Tomás et al., 2008), with the standard normal values
set at 0.05 and a power of 90 %. The calculated minimum sample size for each stage was
rounded up to 40 participants. A sample size of 50 patients was included for stages one, two
and three because these three stages formed the largest group of CKD patients and are the
stages in which CKD is usually diagnosed. Forty patients each were included for stages 4 and
5 and a total of 230 patients were included in the study.
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3.6 Data collection
A structured questionnaire was used for data collection. Saliva collection was done using
graduated sterile bottles, while blood samples were collected using serum separation tubes
(SST) sample bottles specific for analyzing serum creatinine and other blood biochemistry
tests.
3.6.1 Study information Sheet and Questionnaire
A study information sheet (Appendix 5) was given to all the patients and they were allowed
to ask questions about the study. Consenting patients signed the consent form to participate in
the study (Appendix 4) and were advised that they could withdraw from the study at any
stage without affecting their subsequent CKD management at the Renal Unit. Questionnaires
were completed (Appendix 1, 2, 3) in the patients’ respective language. The data captured
included patient sociodemographic information, history of tobacco and alcohol use, medical
history and medication used.
3.6.2 Sample collection
The study participants were recruited in the morning before the commencement of the clinic
and were instructed to refrain from eating and drinking at least 90 minutes before collection.
They were asked to rinse their mouths with water prior to the sample collection, to void the
mouth of contaminants.
The saliva collection procedure was done once the nephrologist had seen the patient and was
only obtained from those patients for whom serum creatinine sampling was indicated. The
patient was given a graduated sterile tube and instructed to sit in a comfortable position with
their eyes open, head tilted slightly forward and to avoid swallowing or making oral
movements during collection. They were asked to pool the saliva in the floor of the mouth
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and collect it in the graduated tube every 60 seconds or when they experienced an urge to
swallow. This process was repeated until 2 mL of whole saliva was obtained. The saliva
collection was carried out between 9:00 am and 12:30 pm, to minimize the effect of diurnal
variation. The patients’ went immediately thereafter to the blood room for venous blood
collection for serum analysis.
3.6.3 Sample analysis
Serum and saliva samples collected were processed and analyzed by enzymatic method for
the determination of serum and salivary creatinine level. Enzymatic method is based on the
conversion of creatinine with the aid of creatininase, creatinase, and sarcosine oxidase to
glycine, formaldehyde and hydrogen peroxide. Catalyzed by peroxidase the liberated
hydrogen peroxide reacts with 4‑aminophenazone and HTIBa to form a quinone imine
chromogen
3.7 Pilot Study
A pilot study was carried out on 5 patients in each of the five stages at the commencement of
the study. The purpose of this process was to test the feasibility of the questionnaire and the
adequacy of the data-capturing sheet. This session also provided an estimate of the time for
salivary sample collection from the patient. The questionnaire was restructured where
necessary.
3.8 Ethical considerations
Approval to conduct the study was granted by the University of the Western Cape
Biomedical Research Ethics Committee (approval number: BM/16/5/4, Appendix 6).
Permission to carry out the research was also obtained from the Tygerberg Hospital Research
Committee (Appendix 7). Patients were made aware of the study and given all the relevant
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information both verbally and in writing. Participation in the study was entirely voluntary and
participants had the right to withdraw at any stage.
Patient anonymity was ensured by assigning study numbers, which were captured on the data
capture sheet and sample tubes. The data capture sheets for each patient enrolled in this study
were kept in a locked drawer.
3.9 Data analysis
The data obtained was entered into an MS Excel sheet and data analysis was done using
SPSS v17.0. Pearson’s correlation coefficient (r) is a measure of the strength of the
association between the two variables and was used to test the correlation between serum and
salivary creatinine levels. Linear regression equations were derived to estimate the plasma
level of creatinine and urea from the salivary levels. Receiver Operating Characteristic
(ROC) analysis was used to evaluate the diagnostic potential of salivary creatinine compared
to blood and to determine if salivary creatinine could distinguish patients with CKD from
healthy individuals. The ROC curve graphically displays the trade-off between sensitivity and
specificity and chooses the best cut-offs for clinical use. The overall performance was
assessed by the Total area under the curve and the cut-off values were determined based on
the best trade-off between the sensitivity and specificity.
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Chapter 4: Results
This chapter shows the results generated from this present study. Table 6 shows the
frequency distribution of patients with CKD stages 1-5 by gender. Table 7 shows the range of
patients’ serum and salivary creatinine with the mean values. The Pearson correlation
analysis is presented in Table 8, while Table 9 shows the linear regression analysis of serum
and salivary creatinine for CKD patients in stages 1 to 5. The results from the Receiver
Operator Characteristics (ROC) curve analysis of serum and salivary creatinine levels are
presented in Tables 10 and 11.
Frequency distribution
The study population comprised a total of 230 CKD patients, of which 50 patients were in
stage 1, 50 patients in stage 2, 50 patients in stage 3, 40 patients in stage 4 and 40 patients in
stage 5.
Table 6: The frequency distribution of patients with CKD stages 1-5 by gender.
Gender Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Total
Male 16 17 23 19 14 89
(38.7%)
Female 34 33 27 21 26 141
(61.3%)
50 50 50 40 40 230
(100%)
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Serum creatinine values (Table 7) for all the patients ranged from 46µmol/L to 1581µmol/L
with a median of 134µmol/L (SD 229.10). Salivary creatinine values ranged from 3umol/L to
400µmol/L with a median of 11µmol/L (SD 50.99).
Table 7: Serum and salivary creatinine values for patients in CKD stages 1-5.
Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Combined
Serum
creatinine
range
(µmol/L)
46 -93 65- 133 102-232 161- 462 312- 1581 46-1581
Median
serum
creatinine
(µmol/L)
66
(14.549)
91
(14.759)
149
(32.167)
276
(50.929)
518
(284.64)
134
(229.10)
Salivary
creatinine
range
(µmol/L)
3 -19 3- 18 4-63 5- 222 72 – 400 3 -400
Median
salivary
creatinine
(µmol/L)
6.2 (5.103) 9 (5.153) 16 (12.638) 28.5(35.72) 67.5 (86.50) 11 ( 50.99)
Spearman correlation analysis (Table 8) was done to determine the association between
serum and salivary creatinine and showed a positive correlation for all CKD stages.
Table 8: Correlation analysis for serum and salivary combined using Spearman
correlation.
Combined Stage 1 Stage 2 Stage 3 Stage 4 Stage 5
R 0.82 0.16 0.31 0.38 0.42 0.55
P 0.00** 0.25 0.03* 0.005** 0.007** 0.00**
Correlation is strong at (r=1.0 to 0.5), moderate at (r=0.3 to 0.5), weak at (r=0.1 to 0.3), no correlation at (r=0.1)
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Figure 1: Correlation between serum and salivary creatinine levels for all CKD patients
combined.
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Figure 2: Correlation between serum and salivary creatinine levels for patients with
CKD stage 1
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Figure 3: Correlation between serum and salivary creatinine level for patients with
stage 2 CKD.
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Figure 4: Correlation between serum and salivary creatinine levels for patients with
stage 3 CKD.
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Figure 5: Correlation between serum and salivary creatinine levels for patients with
stage 4 CKD.
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Figure 6: Correlation between serum and salivary creatinine levels for patients with
stage 5 CKD.
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Table 9 shows linear regression analysis of serum and salivary creatinine for CKD patients.
Linear regression was significant in all stages except for stage 1.
Table 9: Linear regression analysis of serum and salivary creatinine for CKD patients
in stages 1 to 5.
Stage p-value Linear regression equation R2 R2 (%) R
Stage 1 0.465 Y = 64.9 + (0.23) × (Salivary Cr) 0.008 0.80% 0.894
Stage 2 0.030 Y = 89.7 + (0.54) × (Salivary Cr) 0.035 3.50% 0.187
Stage 3 0.008 Y = 134 + (0.95) × (Salivary Cr) 0.140 14.0% 0.374
Stage 4 0.007 Y = 251 + (0.6) × (Salivary Cr) 0.179 17.9% 0.423
Stage 5 0.001 Y = 451 + (1.72) × (Salivary Cr) 0.275 27.5% 0.524
Dependent Variable: Serum Creatinine
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ROC curve
Figure 7: Receiver Operator Characteristics (ROC) curve of serum and salivary
creatinine levels.
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Table 10 shows the area under the curve of ROC curve. The area under the curve for
salivary creatinine is considered good by interpretation considering the value 0.839.
Table 10: Interpretation of area under the curve ROC curve.
Test result variables Area Standard
error
Asymptotic
significance
Asymptotic 95% confidence
interval
Lower bound Upper bound
Serum creatinine
(µmol/L) 0.979 0.008 < 0.01 0.964 0.994
Salivary creatinine
(µmol/L) 0.839 0.028 < 0.001 0.784 0.894
AUC values- Excellent (0.90-1); Good (0.80-0.90); Fair (0.70-0.80); Poor (0.60-0.70); Fail (<0.60)
Table 11 shows cut off values for sensitivity and specificity of salivary creatinine to diagnose
CKD with GFR < 60ml/min. Salivary creatinine is considered to have the best specificity and
sensitivity at salivary creatinine value of 8.50µmol/L.
Table 11: Sensitivity and specificity analysis of salivary creatinine for different cut-off
values considering serum creatinine as the gold standard.
Salivary creatinine
(µmol/L) Sensitivity (%) Specificity (%)
3.50 99.4 26.0
4.50 97.2 26.0
6.50 86.1 56.0
8.50 78.3 74.0
11.50 64.4 88.0
14.5 60.6 90.0
15.5 57.8 92.0
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Chapter 5: Discussion
The present study investigated the role of salivary creatinine as a diagnostic tool for all five
stages of chronic kidney disease (CKD stages 1-5). Previous studies have only evaluated its
potential in patients with CKD stages 4 and 5 (Venkatapathy et al., 2014; Lasisi et al., 2016).
A total of 230 patients with chronic kidney disease were recruited, with 50 patients each in
stages one to three and 40 patients in stages four and five. The participants were stratified this
way as stages 1 to 3 have the highest prevalence in the general population, while stages 4 and
5 have the least (Moorman et al., 2007). The age range of patients was 18 - 82 years. The
mean age was 39.5 years (SD 13.05) and was comparable to other studies by Lasisi et al.,
2016 and Venkatapathy et al., 2014, who reported a mean age of 39.5 and 47.5 respectively
Studies (Coresh et al., 2007; Prakash et al., 2009) have found CKD to be more prevalent in
persons aged 60 years and older. This higher prevalence in older patients may reflect the
different risk factors for CKD, such as diabetes and hypertension, which are more common in
older individuals. In addition, high rates of CKD in older patients may also occur due to an
age-associated decline in kidney function (Prakash and O'Hare, 2009).
There were more females (61.3%) than males in the study population. This is in accordance
with others studies, which found a higher prevalence of CKD among females in United States
(Coresh et al., 2003; Coresh et al., 2005) and  Western Cape, South Africa (Matsha et al.,
2013). This increased female prevalence may be due to fact that diabetes mellitus (DM), the
most common cause of chronic kidney disease is more prevalent amongst females (Hilawe et
al., 2013; Mbanya et al., 1997).
http://etd.uwc.ac.za/
  
 
 
35
Serum creatinine median value for all the patients was 134µmol/L (range=46µmol/L-
1581µmol/L) while salivary creatinine median value was 11 µmol/L (range= 3µmol/L-
400µmol/L). The range of serum and salivary creatinine for patients in stage 1 fell within the
normal range. This result is in line with the knowledge about CKD patients and is reflected in
the classification of CKD, in which stage 1 patients usually have a normal estimated GFR
(eGFR) and their creatinine values fall within normal range of serum and salivary creatinine.
In this study, we observed an increasing level of serum and salivary creatinine from CKD
stages 2 to 5. CKD stage 5 has the highest values for both serum and salivary creatinine. This
finding is in accordance with previous studies in which elevated levels of serum and salivary
creatinine was found in end stage renal disease (Venkatapathy et al., 2014; Lasisi et al.,
2016). The increase in serum creatinine, which progressively increased from stage 2 to 5, is
due to the fall in GFR leading to reduced creatinine excretion via the kidneys. The fall in
GFR has been attributed to a decrease in either glomerular capillary surface area or hydraulic
permeability (Perrone et al., 1992). An increased serum creatinine creates a concentration
gradient, which increases the diffusion of creatinine from serum to saliva, thereby increasing
the salivary creatinine concentration.
A Spearman’s correlation analysis was done to determine the association between salivary
and serum creatinine in CKD stages 1-5 and to determine their proportionality. A strong
positive correlation (r = 0.82) between serum and salivary creatinine was found in the
combined analysis of all CKD stages (Figure 1). Lloyd et al. (1996) reported a similar pattern
in patients with CKD stages 4 and 5. The positive correlation observed in the present study
may be due to the progressive alteration in salivary gland cell permeability as well as
impaired endothelium-dependent dilation (EDD) associated with the vascular system of
patients with chronic kidney diseases (Lakatta and Levy, 2003).  This leads to an increased
diffusion of creatinine from serum to saliva, (Nakahari et al., 1996).
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Correlation studies between serum and salivary creatinine in healthy patients have reported
conflicting results. Bader et al. (2015) found a positive correlation between the serum and
salivary creatinine in patients without chronic kidney disease, while other studies reported a
negative correlation (Venkatapathy et al., 2014; Lasisi et al., 2016). The different reports
from the studies may be due to other local and systemic factors such as diabetes mellitus and
hypertension and salivary gland diseases, which can alter the diffusion of creatinine from
serum into the salivary glands (Ladgotraet al., 2016; Briet et al., 2011). Other factors that
could be responsible for the difference in correlation are the medications, which the patients
were using at the time the samples were collected, which were not considered in the present
nor previous studies.
A linear regression analysis was used to determine the functional relationship between serum
and salivary creatinine and to predict cut off values (Table 7). A significant relationship was
found for serum and salivary creatinine in CKD stages 2 to 5 with stage 5 having the highest
coefficient of determination of 27.5%. A linear regression established that salivary creatinine
in stage 5 could statistically significantly predict serum creatinine concentration, F(1, 38) =
39, p < .001 and salivary creatinine accounted for 27.5 % of the explained variability in
serum creatinine concentration. It should be noted that the generally low coefficient of
determination (R2) does not mean that salivary creatinine is not a good predictor of serum
creatinine. Other confounding factors such as patients comorbidities and medications, which
were not considered in this study can affect the level of serum creatinine and the rate at which
it can be predicted by saliva. The significant relationship in stages 2-5 is in line with
previous studies in which a significant predictive relationship was found between serum and
salivary creatinine in CKD stages 4 and 5.  For CKD stage 1, the relationship between serum
and salivary creatinine was not significant. This was expected and consistent with results of
previous studies (Venkatapathy et al., 2014; Lasisi et al., 2016), whose serum and salivary
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creatinine values were within normal range. The non-significant relationship in stage 1 can
be due to normal serum creatinine level found in stage 1 patients and which there is only
minimal movement of creatinine from serum to saliva at this level.
In order to replace the serum creatinine test with a salivary diagnostic test, the diagnostic
value of salivary creatinine test must be compared with that of the presently accepted method
for diagnosing of CKD. The accuracy of the new test is determined by the strength with
which it separates the group being tested into those with the disease and without the disease
(Brown Connolly, 2014). Specificity and sensitivity of the diagnostic test is the basic method
used to measure accuracy of the diagnostic test. In addition, positive predictive value (PPV)
and negative predictive value (NPV) which show the percentage of group who tested positive
who truly have the disease and the group which tested negative who do not have the disease
give a better indication of how close a new diagnostic tool is close the gold standard. This is
because the PPV and NPV are directly related to the prevalence of the disease in the sample
population.
ROC analysis (Figure 7) of salivary creatinine revealed a good sensitivity and specificity
range. The area under the curve (0.839) obtained in the present study for salivary creatinine
showed salivary creatinine to be a good alternative diagnostic test to differentiate healthy and
CKD patients. Comparable large areas under the curve were obtained from previous studies.
Xia et al. (2012) obtained an area under curve value of 0.897, while Ventakapathy et al. 2014
obtained an area under curve of 0.967.
In the present study, significant ROC analysis cut-off points were measured at 8.50µmol/L,
which gave a sensitivity of 78.3% (false negative rate = 21.7%) and specificity of 74.0%
(false positive rate = 26%) (Table 9). The PPV in this study is 91.6% while the NPV is
48.7%. The high PPV shows that the saliva as a diagnostic tool can be as good as serum
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creatinine in diagnosis of CKD. However, the low NPV in this study is a reflection of the
relatively high prevalence of CKD (17.3%) in the South African population. This suggests
that people with salivary creatinine values above 8.50µmol/L be referred for further
diagnostic evaluation and appropriate management.
Thus the results of the present study, supports the potential use of saliva as an alternative
diagnostic medium to estimate serum creatinine in patients’ with chronic kidney disease, but
needs to be evaluated in longitudinal studies. The present study is the first to report a positive
correlation as well as a predictive relationship in CKD stages 1 to 3.
Conclusion
The results of the study has contributed to the existing data on the diagnostic potential of
salivary creatinine as a non-invasive diagnostic tool to estimate serum creatinine in patients
with chronic kidney disease.
Limitations of the study
The limitation of this study design is that only a single salivary sample was taken from
patients. Other limitation is non-inclusion of healthy control group. A prospective, cohort
study is needed to test and verify our conclusions.
Recommendations
Patient stratification by sociodemographic factors such as gender, age and race, used in the
calculation of glomerular filtration rate are needed to develop a specific GFR formula for
calculating salivary creatinine. Further longitudinal studies are recommended to evaluate the
potential use of saliva for monitoring CKD patients, as creatinine levels may be influenced by
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different factors such as medications, diet, liver function and intense exercise. The effect of
other systemic conditions such as diabetes mellitus, hypertension and obesity on salivary
creatinine levels, as well as evaluation of other CKD markers (such as urea) in saliva at all
stages of CKD, needs further investigation. Further investigations to determine if exogenous
radioactive labelled tracers, which are more accurate but also costly, are detectable in saliva.
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